Placeholder Banner

BIO's Dr. Michelle McMurry-Heath Responds to "Unconscionable" Attacks on U.S. Capitol

January 6, 2021
Media Contact
JG
2027471281

Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization, made the following comments in response to today's violence at the United States Capitol:

"Today we watched in horror as angry and unruly mobs attacked the United States Capitol in an effort to overturn the results of a democratically held election.

"At BIO, we vigorously supported and encouraged scientists of all sorts to become actively involved in the political process, support their candidates from whichever party, and make their voices heard by voting. In an unprecedented election, millions of voters went to the polls and did just that.

"It is simply unconscionable for an angry mob, upset by an election outcome to try to disenfranchise the votes of millions of Americans simply because their chosen candidate lost.

"As we are staring down a global pandemic, it is now more critical than ever for Congress to return to their important work and join together in a unified front to fight the disease and not each other. The time has come for leaders of both political parties to collectively say enough is enough and return our country to civility and the rule of law."

 

Discover More
The Biotechnology Innovation Organization (BIO) is proud to announce that industry leader and military veteran John F. Crowley will be its new President and CEO, effective March 4. He will replace Rachel King, a longtime BIO board member and…
Biotechnology companies are hard at work on the cutting-edge innovations we need, but those breakthroughs are at risk from current tax policy. The Biotechnology Innovation Organization, which represents more than 1,000 biotech companies, thanks…
President Biden today unveiled details of the White House’s budget request that included drastic changes to the Medicare program, including further expanding the program’s new authority to institute price controls in Medicare. BIO Chief Advocacy…